Cybin Therapeutics aims to identify formulations, design therapeutic processes for research, and collect data for clinical trials. Our goal is to identify protocols that are complimented by formulations to optimize patient outcomes.
We take a therapeutic-focused approach.
Cybin Therapeutics is undertaking therapeutic protocol and development using natural psilocybin-based formulations to address varying mood and addiction disorders. The company is currently:
- Finished first Health Canada applications.
- Identifying and preparing for additional study applications.
- Establishing first clinic.
Industry News & Updates
Please click on the links below for the latest news and updates from the industry.
JOIN THE FUTURE OF MENTAL HEALTH THERAPY.
